EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
Stopped Due to lack of funding and a primary co-investigator of the trial leaving the institution.
Conditions
- Adult Brain Glioblastoma
- Adult Gliosarcoma
- Recurrent Brain Neoplasm
Interventions
- BIOLOGICAL: EGFRBi-Armed Autologous T Cells
- OTHER: Laboratory Biomarker Analysis
Sponsor
Barbara Ann Karmanos Cancer Institute
Collaborators